Becton, Dickinson and Company (NYSE:BDX) Shares Sold by United Services Automobile Association

United Services Automobile Association cut its position in shares of Becton, Dickinson and Company (NYSE:BDX) by 23.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 93,168 shares of the medical instruments supplier’s stock after selling 28,311 shares during the period. United Services Automobile Association’s holdings in Becton, Dickinson and were worth $17,091,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. North Star Investment Management Corp. increased its stake in shares of Becton, Dickinson and by 3.4% in the first quarter. North Star Investment Management Corp. now owns 549 shares of the medical instruments supplier’s stock valued at $101,000 after buying an additional 18 shares in the last quarter. Crestwood Advisors Group LLC purchased a new stake in shares of Becton, Dickinson and during the first quarter valued at approximately $101,000. Parkside Financial Bank & Trust increased its stake in shares of Becton, Dickinson and by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 633 shares of the medical instruments supplier’s stock valued at $116,000 after buying an additional 9 shares in the last quarter. Financial Architects Inc increased its stake in shares of Becton, Dickinson and by 62.7% in the first quarter. Financial Architects Inc now owns 677 shares of the medical instruments supplier’s stock valued at $124,000 after buying an additional 261 shares in the last quarter. Finally, QCI Asset Management Inc. NY increased its stake in shares of Becton, Dickinson and by 9.2% in the first quarter. QCI Asset Management Inc. NY now owns 710 shares of the medical instruments supplier’s stock valued at $130,000 after buying an additional 60 shares in the last quarter. 75.57% of the stock is currently owned by hedge funds and other institutional investors.

Becton, Dickinson and Company (BDX) traded up 0.70% during mid-day trading on Monday, reaching $201.77. 1,558,912 shares of the company were exchanged. The stock has a 50-day moving average price of $198.90 and a 200 day moving average price of $187.70. Becton, Dickinson and Company has a one year low of $161.29 and a one year high of $206.63. The company has a market capitalization of $45.92 billion, a PE ratio of 58.43 and a beta of 1.05.

Becton, Dickinson and (NYSE:BDX) last released its quarterly earnings results on Thursday, August 3rd. The medical instruments supplier reported $2.46 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.44 by $0.02. Becton, Dickinson and had a net margin of 6.25% and a return on equity of 22.53%. The firm had revenue of $3.04 billion during the quarter, compared to analyst estimates of $3.06 billion. During the same quarter in the prior year, the firm earned $2.35 EPS. The business’s revenue for the quarter was down 5.1% compared to the same quarter last year. Analysts predict that Becton, Dickinson and Company will post $9.46 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 29th. Stockholders of record on Friday, September 8th will be given a dividend of $0.73 per share. This represents a $2.92 annualized dividend and a dividend yield of 1.45%. The ex-dividend date is Thursday, September 7th. Becton, Dickinson and’s payout ratio is currently 83.43%.

COPYRIGHT VIOLATION NOTICE: This article was first posted by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this article on another publication, it was stolen and reposted in violation of US and international copyright law. The original version of this article can be viewed at https://transcriptdaily.com/2017/08/14/united-services-automobile-association-lowers-stake-in-becton-dickinson-and-company-nysebdx-updated-updated-updated.html.

Several brokerages have recently commented on BDX. Cowen and Company reiterated a “buy” rating and issued a $230.00 target price on shares of Becton, Dickinson and in a report on Monday. Barclays PLC reiterated an “equal weight” rating and issued a $210.00 target price (up previously from $205.00) on shares of Becton, Dickinson and in a report on Thursday. Stifel Nicolaus reiterated a “buy” rating on shares of Becton, Dickinson and in a report on Wednesday, August 9th. Zacks Investment Research downgraded shares of Becton, Dickinson and from a “buy” rating to a “hold” rating in a report on Monday, August 7th. Finally, BidaskClub downgraded shares of Becton, Dickinson and from a “buy” rating to a “hold” rating in a report on Sunday, August 6th. One analyst has rated the stock with a sell rating, six have issued a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. Becton, Dickinson and currently has an average rating of “Buy” and a consensus price target of $195.79.

In other news, VP Jeffrey S. Sherman sold 28,765 shares of the company’s stock in a transaction dated Thursday, May 25th. The shares were sold at an average price of $185.98, for a total transaction of $5,349,714.70. Following the completion of the sale, the vice president now owns 70,821 shares of the company’s stock, valued at approximately $13,171,289.58. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Thomas E. Polen, Jr. sold 5,971 shares of the company’s stock in a transaction dated Wednesday, August 9th. The shares were sold at an average price of $197.41, for a total transaction of $1,178,735.11. Following the sale, the insider now directly owns 12,861 shares of the company’s stock, valued at approximately $2,538,890.01. The disclosure for this sale can be found here. Insiders have sold a total of 44,019 shares of company stock valued at $8,368,433 in the last ninety days. Insiders own 1.40% of the company’s stock.

Becton, Dickinson and Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)




Receive News & Ratings for Becton Dickinson and Company Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Becton Dickinson and Company and related companies with MarketBeat.com’s FREE daily email newsletter.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

8 − three =